EGFR and breast cancer: One interesting example of this type of modification was reported by Ohno and colleagues, where they engineered exosomes to express an epidermal growth factor receptor (EGFR)-specific targeting peptide, GE11, on their surfaces, which were then subsequently used to target a TS miRNA to EGFR-expressing breast cancer cells [156].